BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34854538)

  • 1. Sharing psychosocial risk screening information with pediatric oncology healthcare providers: Service utilization and related factors.
    Etkin-Spigelman L; Hancock K; Nathan PC; Barrera M
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29456. PubMed ID: 34854538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in pediatric oncology patients, caregivers and siblings after psychosocial screening: a randomized controlled trial.
    Barrera M; Hancock K; Atenafu E; Alexander S; Solomon A; Desjardins L; Shama W; Chung J; Mills D
    Support Care Cancer; 2020 Aug; 28(8):3659-3668. PubMed ID: 31811485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative examination of the benefits and challenges of a psychosocial screening intervention in pediatric oncology: "Support comes to us".
    Hancock K; Barrera M; Prasad S; Desjardins L; Shama W; Alexander S; Szatmari P
    Pediatr Blood Cancer; 2022 May; 69(5):e29578. PubMed ID: 35084106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare provider utility ratings of a psychosocial screening summary: from diagnosis to 6 months.
    Desjardins L; Etkin-Spigelman L; Hancock K; Chung J; Shama W; Mills D; Alexander S; Barrera M
    Support Care Cancer; 2020 Apr; 28(4):1717-1723. PubMed ID: 31292754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early trajectory of psychosocial risk in families of children and adolescents newly diagnosed with cancer.
    Barrera M; Young MA; Hancock K; Chung J
    Support Care Cancer; 2022 Feb; 30(2):1815-1822. PubMed ID: 34608532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and change in family psychosocial risk over 6 months in pediatric cancer and its association with medical and psychosocial healthcare utilization.
    Kazak AE; Chen FF; Hwang WT; Askins MA; Vega G; Kolb EA; Reilly A; Barakat LP
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28051. PubMed ID: 31724814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial screening and mental health in pediatric cancer: A randomized controlled trial.
    Barrera M; Alexander S; Atenafu EG; Chung J; Hancock K; Solomon A; Desjardins L; Shama W; Mills D
    Health Psychol; 2020 May; 39(5):381-390. PubMed ID: 31971403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial difficulties identified by health care providers as they predict pain-related quality of life in children with cancer.
    Nofech-Mozes J; Hancock K; Chung J; Barrera M
    Support Care Cancer; 2020 Jul; 28(7):3459-3466. PubMed ID: 31802251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of systematic poverty screening in a pediatric oncology referral center.
    Zheng DJ; Shyr D; Ma C; Muriel AC; Wolfe J; Bona K
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27380. PubMed ID: 30069999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying psychosocial risk indicative of subsequent resource use in families of newly diagnosed pediatric oncology patients.
    Kazak AE; Cant MC; Jensen MM; McSherry M; Rourke MT; Hwang WT; Alderfer MA; Beele D; Simms S; Lange BJ
    J Clin Oncol; 2003 Sep; 21(17):3220-5. PubMed ID: 12947055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Match of psychosocial risk and psychosocial care in families of a child with cancer.
    Sint Nicolaas SM; Schepers SA; van den Bergh EMM; de Boer Y; Streng I; van Dijk-Lokkart EM; Grootenhuis MA; Verhaak CM
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28914485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for mapping psychosocial screening to resources in pediatric oncology: a pilot randomized controlled trial.
    Desjardins L; Hancock K; Szatmari P; Alexander S; Shama W; De Souza C; Mills D; Abla O; Barrera M
    Pilot Feasibility Stud; 2021 Jul; 7(1):143. PubMed ID: 34274016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family psychosocial risk, distress, and service utilization in pediatric cancer: predictive validity of the Psychosocial Assessment Tool.
    Alderfer MA; Mougianis I; Barakat LP; Beele D; DiTaranto S; Hwang WT; Reilly AT; Kazak AE
    Cancer; 2009 Sep; 115(18 Suppl):4339-49. PubMed ID: 19731359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot randomized psychosocial trial of a screening intervention in pediatric oncology.
    Barrera M; Desjardins L; Prasad S; Shama W; Alexander S; Szatmari P; Hancock K
    Psychooncology; 2022 May; 31(5):735-744. PubMed ID: 34813129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Family Psychosocial Risk in Pediatric Hematopoietic Stem Cell Transplantation with the Psychosocial Assessment Tool.
    Pai ALH; Swain AM; Chen FF; Hwang WT; Vega G; Carlson O; Ortiz FA; Canter K; Joffe N; Kolb EA; Davies SM; Chewning JH; Deatrick J; Kazak AE
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1374-1381. PubMed ID: 30878608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Family Psychosocial Risk in Pediatric Cancer: Validation of the Psychosocial Assessment Tool (PAT) Version 3.
    Kazak AE; Hwang WT; Chen FF; Askins MA; Carlson O; Argueta-Ortiz F; Barakat LP
    J Pediatr Psychol; 2018 Aug; 43(7):737-748. PubMed ID: 29509908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for psychosocial risk at pediatric cancer diagnosis: the psychosocial assessment tool.
    Kazak AE; Barakat LP; Ditaranto S; Biros D; Hwang WT; Beele D; Kersun L; Alderfer MA; Mougianis I; Hocking MC; Reilly A
    J Pediatr Hematol Oncol; 2011 May; 33(4):289-94. PubMed ID: 21516024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Spanish Version of the Psychosocial Assessment Tool (PAT) in Pediatric Cancer.
    Kazak AE; Hwang WT; Chen FF; Askins MA; Carlson O; Argueta-Ortiz F; Vega G; Barakat LP
    J Pediatr Psychol; 2018 Nov; 43(10):1104-1113. PubMed ID: 29982606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caregiver distress and patient health-related quality of life: psychosocial screening during pediatric cancer treatment.
    Pierce L; Hocking MC; Schwartz LA; Alderfer MA; Kazak AE; Barakat LP
    Psychooncology; 2017 Oct; 26(10):1555-1561. PubMed ID: 27321897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceived benefits of and barriers to psychosocial risk screening in pediatric oncology by health care providers.
    Barrera M; Alexander S; Shama W; Mills D; Desjardins L; Hancock K
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27429. PubMed ID: 30160072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.